Secondary Marketplace / Trade Private Companies / Buy and Sell Sema4 Stock
Sema4 Sema4 Stock
$1.47B
Series C Valuation, Jul 2020
Register To Buy and Sell Private Company Shares
For more details on financing and valuation of private companies similar to Sema4 before its SPAC, register or login today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Sign in

Sema4 Stock Price

Forge Price 1
Price not available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Sema4 Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
07/29/2020 Series C $121.4MM $xx.xx $1.47B Blackrock, Blackstone, Connecticut Innovations, Decheng, Deerfield Management Company, Moore Strategic Ventures, Oak Hc/Ft, Section 32
Price per Share
$xx.xx
Shares Outstanding
197,824
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blackrock, Blackstone, Connecticut Innovations, Decheng, Deerfield Management Company, Moore Strategic Ventures, Oak Hc/Ft, Section 32
08/22/2019 Series B $127.61MM $xx.xx $577.68MM Connecticut Innovations, Decheng, Mount Sinai Health System, Oak Hc/Ft
Price per Share
$xx.xx
Shares Outstanding
338,663
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.6x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Connecticut Innovations, Decheng, Mount Sinai Health System, Oak Hc/Ft
03/21/2018 Series A-2 $64.25MM $xx.xx $145.93MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
522,627
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
03/21/2018 Series A-1 $55MM $xx.xx $145.93MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
447,373
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
Company Details
Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.
Post-Money Valuation 3
$1.47B
Total Funding
$368.26MM
LFR Price per Share
$xx.xx
Last Funding Share Class
Series C
Sema4 Stock FAQs
To buy and sell Sema4 stock
Can you buy Sema4 stock?
You can no longer buy Sema4 stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
How to buy Sema4 stock?
You can no longer buy Sema4 stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
Can you sell Sema4 stock?
You can no longer sell stock of Sema4 on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
How to sell Sema4 stock?
You can no longer sell stock of Sema4 on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
To learn more about Sema4 stock
Is Sema4 a public company?
Sema4 is now a public company traded on NASDAQ with ticker SMFR.
What is Sema4’s stock price?
The stock price of Sema4 is $0.3106 as of 1/9/23.
What is Sema4’s stock ticker symbol?
The ticker symbol of Sema4 is SMFR.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Sema4 News and Media Highlights

Sema4 to Study Precision Oncology Disparities in Nationwide Biobanking, Genomic Profiling Study

The firm will use its suite of assays to characterize samples from 5,000 advanced cancer patients from underserved communities and create a representative biobank.

Sema4 Q4 Revenues Decline 10 Percent

Sema4 beat the consensus Wall Street estimate on the top and bottom lines for Q4 and said it expects between $215 million and $225 million in revenues for 2022.
Browse Insights
Explore Private Companies in the Healthcare providers & services Sector
Sector: Healthcare
Subsector: Healthcare providers & services
Last Funding Round
Company Forge Price Forge Price Change 5 Last Closed Trade Share Class Post-Money Valuation Price per Share Amount Raised
Cityblock HealthCityblock Health$19.91+95.96%$xx.xxSeries X$1.58B$xx.xx$39MM
ColorColor----$xx.xxSeries E$4.6B$xx.xx$100MM
DandyDandy----$xx.xxSeries Seed-1$10.41MM$xx.xx$2.63MM
Devoted HealthDevoted Health----$xx.xxSeries E$13.03B$xx.xx$287MM
HeartFlowHeartFlow$7.28+54.56%$xx.xxSeries E$1.65B$xx.xx$305MM
Komodo HealthKomodo Health----$xx.xxSeries E$3.21B$xx.xx$119.98MM
Mark Cuban Cost Plus Drug CompanyMark Cuban Cost Plus Drug Company----$xx.xx--------
Sword HealthSword Health----$xx.xxSeries E$3B$xx.xx$30MM
Virta HealthVirta Health----$xx.xxSeries E$2.18B$xx.xx$133.37MM
Vytalize HealthVytalize Health----$xx.xx--------

Updated on: Jan 22, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.